BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15743364)

  • 1. Estimation of utilities for chronic hepatitis C from SF-36 scores.
    Thein HH; Krahn M; Kaldor JM; Dore GJ
    Am J Gastroenterol; 2005 Mar; 100(3):643-51. PubMed ID: 15743364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comorbidities and quality of life in patients with interferon-refractory chronic hepatitis C.
    Fontana RJ; Moyer CA; Sonnad S; Lok ASF ; Sneed-Pee N; Walsh J; Klein S; Webster S
    Am J Gastroenterol; 2001 Jan; 96(1):170-8. PubMed ID: 11197249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of chronic liver disease and cirrhosis on health utilities using SF-6D and the health utility index.
    Dan AA; Kallman JB; Srivastava R; Younoszai Z; Kim A; Younossi ZM
    Liver Transpl; 2008 Mar; 14(3):321-6. PubMed ID: 18306356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained responders have better quality of life and productivity compared with treatment failures long after antiviral therapy for hepatitis C.
    John-Baptiste AA; Tomlinson G; Hsu PC; Krajden M; Heathcote EJ; Laporte A; Yoshida EM; Anderson FH; Krahn MD
    Am J Gastroenterol; 2009 Oct; 104(10):2439-48. PubMed ID: 19568230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health utilities and psychometric quality of life in patients with early- and late-stage hepatitis C virus infection.
    Hsu PC; Federico CA; Krajden M; Yoshida EM; Bremner KE; Anderson FH; Weiss AA; Krahn MD
    J Gastroenterol Hepatol; 2012 Jan; 27(1):149-57. PubMed ID: 21679248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does cirrhosis affect quality of life in hepatitis C virus-infected patients?
    Hsu PC; Krajden M; Yoshida EM; Anderson FH; Tomlinson GA; Krahn MD
    Liver Int; 2009 Mar; 29(3):449-58. PubMed ID: 19267865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life in patients with different stages of liver disease induced by hepatitis C.
    Björnsson E; Verbaan H; Oksanen A; Frydén A; Johansson J; Friberg S; Dalgård O; Kalaitzakis E
    Scand J Gastroenterol; 2009; 44(7):878-87. PubMed ID: 19437190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biopsychosocial predictors of health-related quality of life in patients with chronic hepatitis C.
    Häuser W; Zimmer C; Schiedermaier P; Grandt D
    Psychosom Med; 2004; 66(6):954-8. PubMed ID: 15564364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of utilities and health-related quality of life in patients with chronic liver disease.
    Younossi ZM; Boparai N; McCormick M; Price LL; Guyatt G
    Am J Gastroenterol; 2001 Feb; 96(2):579-83. PubMed ID: 11232711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host- rather than virus-related factors reduce health-related quality of life in hepatitis C virus infection.
    Helbling B; Overbeck K; Gonvers JJ; Malinverni R; Dufour JF; Borovicka J; Heim M; Cerny A; Negro F; Bucher S; Rickenbach M; Renner EL; Mullhaupt B;
    Gut; 2008 Nov; 57(11):1597-603. PubMed ID: 18625696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in socio-economics, quality of life and knowledge of patients with chronic hepatitis C during the Hepatitis Competence Net Project].
    Niederau C; Bemba G; Kautz A
    Z Gastroenterol; 2008 Jan; 46(1):22-33. PubMed ID: 18188813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deterioration of health-related quality of life and fatigue in patients with chronic hepatitis C: Association with demographic factors, inflammatory activity, and degree of fibrosis.
    Teuber G; Schäfer A; Rimpel J; Paul K; Keicher C; Scheurlen M; Zeuzem S; Kraus MR
    J Hepatol; 2008 Dec; 49(6):923-9. PubMed ID: 18929420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan.
    Yu ML; Lin SM; Chuang WL; Dai CY; Wang JH; Lu SN; Sheen IS; Chang WY; Lee CM; Liaw YF
    Antivir Ther; 2006; 11(8):985-94. PubMed ID: 17302368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Productivity improvements in hepatitis C treatment: impact on efficacy, cost, cost-effectiveness and quality of life.
    Lidgren M; Hollander A; Weiland O; Jönsson B
    Scand J Gastroenterol; 2007 Jul; 42(7):867-77. PubMed ID: 17558912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health values of patients with chronic hepatitis C infection.
    Sherman KE; Sherman SN; Chenier T; Tsevat J
    Arch Intern Med; 2004 Nov; 164(21):2377-82. PubMed ID: 15557419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.
    Maylin S; Martinot-Peignoux M; Moucari R; Boyer N; Ripault MP; Cazals-Hatem D; Giuily N; Castelnau C; Cardoso AC; Asselah T; Féray C; Nicolas-Chanoine MH; Bedossa P; Marcellin P
    Gastroenterology; 2008 Sep; 135(3):821-9. PubMed ID: 18593587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life in methadone maintenance patients with untreated hepatitis C virus infection.
    Batki SL; Canfield KM; Smyth E; Ploutz-Snyder R
    Drug Alcohol Depend; 2009 May; 101(3):176-82. PubMed ID: 19233573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbid illness is an important determinant of health-related quality of life in patients with chronic hepatitis C.
    Hussain KB; Fontana RJ; Moyer CA; Su GL; Sneed-Pee N; Lok AS
    Am J Gastroenterol; 2001 Sep; 96(9):2737-44. PubMed ID: 11569704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of interferon alpha plus ribavirin on health-related quality of life in chronic C hepatitis. The Romanian experience.
    Pojoga C; Dumitraşcu DL; Pascu O; Grigorescu M
    J Gastrointestin Liver Dis; 2006 Mar; 15(1):31-5. PubMed ID: 16680230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The relationship between emotional distress, cognitive performance and health - related quality of life in patients with hepatitis C prior to antiviral treatment].
    Rothenhäusler HB; Scherr M; Putz-Bankuti C; Kapper A; Stepan A; Baranyi A; Haas-Krammer A; Haas B; Stauber R
    Fortschr Neurol Psychiatr; 2009 Aug; 77(8):457-63. PubMed ID: 19676008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.